|
|
|
|
 |
| AUGUST 27 ,
2009 | ISSUE NUMBER 113 VOL 6 |
Warning Letters
Feds Chase Down Faulty Skincare Promos
Acne and anti-inflammatory drugs are having a bad week as DDMAC slapped three pharma companies with warning and untitled letters for misleading journal and professional advertisements.
Regulatory
FDA Readies More Warning Letters, Pledges Fast Enforcement
FDA officials have been promising stiffer enforcement of manufacturing and marketing requirements for several months, and commissioner Margaret Hamburg is moving full-speed ahead to fulfill those predictions.
New Media
Pfizer to Launch Clinical Trial Network
It might not be a social network in the truest sense, but Pfizer has plans to build a community where pharma companies can easily recruit and supply health information to patients searching the vast wasteland of clinical trial programs.
In The Magazine
What's the Deal at Solvay?
The Belgian drugmaker is pursuing a sale, inking deals, issuing debt, and launching a power drug for Parkinson's—all at once.
|
 |
|  Giles & Associates Consultancy appointed Aimee H. Berner as principal // Eiger BioPharmaceuticals appointed Paul Truex to its board of directors // Helix BioPharma appointed Kazimierz Roszkowski-Sliz, M.D., to its board of directors // Laureate Pharma elected Joel A. Tune as a new member of its board of directors // GENova Biotherapeutics named Aaron Whiteman CEO // AbelsonTaylor promoted Brittany Cripe, Jane Valadka, and Meghan Jones to account executive // Malcolm MacCoss, group vice president, chemical research, Schering-Plough Research Institute, has been selected for the American Chemical Society’s Medicinal Chemistry Hall of Fame // CommonHealth promoted Christopher Dufty to senior program director and Karen Auteri to program manager // Palio formalized a partnership with Zemoga, a full-service interactive agency, to tackle the changing nature of digital media // Patient interaction, the clinical trial team at Progressive Impressions International, claimed two Award of Distinction statuettes at the 15th annual Communicator Awards //
|
September
10 An Evolving Standard for Success: Proving Product Value Through Comparative Effectiveness Data
Wednesday, September 10 at 11 AM EDT
September 14 Develop Competitive Advantage Through Business Analytics in the New Pharmaceutical Commercial Model
Wednesday, September 14 at 11 AM EDT
|
September
14–15 4th Annual Forum on Educational Grants for the Bio/Pharmaceutical Industry,
Philadelphia, PA
September
21–24 5th
Annual Process Excellence Week for the Service & Transactional
World, Chicago, IL
September
30 Prix Galien 2009 Awards Ceremony, New York, NY
October
5–7 BioNetwork
2009: The 7th Annual Pharmaceutical-Biotech Partnering
Conference, Laguna Niguel, California
October
20–21 CBI’s Leadership Summit on Global Interactions with Healthcare Providers, Arlington, VA |
|
|
|
 |
|
 |
|
 |
| Are you seeking to build a defined strategic capability to communicate and engage in this emerging area of cyberspace? |
|
|
|
|
You are subscribed to Pharm Exec Direct..
To unsubscribe,
click here
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
